Seki, Yoshitaka, Okusaka, Takuji, Ikeda, Masafumi, Morizane, Chigusa, Ueno, Hideki
Pancreatic acinar cell carcinoma (ACC) is a comparatively rare tumor and account for ∼1% of all cases of pancreatic cancer. Clinical presentation is usually related to either local spread or...
Ikeda, Masafumi, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Kojima, Yasushi, Iwasa, Satoru, ...
Objective Systemic chemotherapy is an important treatment modality for metastatic hepatocellular carcinoma (HCC); however, the predictive factors of outcome and tumor response have not been fully...
Tanaka, Tsutomu, Ikeda, Masafumi, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Hagihara, Atsushi, ...
Objective The purpose of the retrospective analysis is to elucidate the treatment efficacy and toxicity as well as to identify prognostic factors in Japanese patients with advanced pancreatic cancer...
Ueno, Hideki, Okusaka, Takuji, Ikeda, Masafumi, Morizane, Chigusa, Ogura, Takashi, Hagihara, Atsushi, ...
Objective The objectives of this study were to evaluate the efficacy and toxicity of combination chemotherapy with gemcitabine and cisplatin in patients with metastatic pancreatic cancer. Methods...
Yonemoto, Naohiro, Furuse, Junji, Okusaka, Takuji, Yamao, Kenji, Funakoshi, Akihiro, Ohkawa, Shinichi, ...
Background This study examined the effect of five systemic chemotherapy regimens on survival in patients with unresectable biliary tract cancer (BTC) as compared with the best supportive care (BSC). ...
Okusaka, Takuji, Ishii, Hiroshi, Funakoshi, Akihiro, Ueno, Hideki, Furuse, Junji, Sumii, Toshihiko
Background: In an effort to improve efficacy of single-agent gemcitabine in pancreatic cancer, several studies have examined the effects of 5-FU combined with gemcitabine. However, no studies to date...
Furuse, Junji, Okusaka, Takuji, Funakoshi, Akihiro, Yamao, Kenji, Nagase, Michitaka, Ishii, Hiroshi, ...
Background: Standard chemotherapy for advanced biliary tract cancer has not been established. The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of...
Furuse, Junji, Okusaka, Takuji, Funakoshi, Akihiro, Yamao, Kenji, Nagase, Michitaka, Ishii, Hiroshi, ...
Background: Standard chemotherapy for advanced biliary tract cancer has not been established. The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of...
Okusaka, Takuji, Ishii, Hiroshi, Funakoshi, Akihiro, Ueno, Hideki, Furuse, Junji, Sumii, Toshihiko
Background: In an effort to improve efficacy of single-agent gemcitabine in pancreatic cancer, several studies have examined the effects of 5-FU combined with gemcitabine. However, no studies to date...
A Phase II Trial of Uracil-Tegafur (UFT) in Patients with Advanced Biliary Tract Carcinoma (2005)
Ikeda, Masafumi, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Furuse, Junji, Ishii, Hiroshi
Background: Uracil-tegafur (UFT) has been reported to have broad antitumor activity in a variety of malignancies. However, its activity in biliary tract carcinoma has not been fully evaluated. The...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...
A Phase II Trial of Uracil-Tegafur (UFT) in Patients with Advanced Biliary Tract Carcinoma (2005)
Ikeda, Masafumi, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Furuse, Junji, Ishii, Hiroshi
Background: Uracil–tegafur (UFT) has been reported to have broad antitumor activity in a variety of malignancies. However, its activity in biliary tract carcinoma has not been fully evaluated. The...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients...
A Phase II Trial of Uracil-Tegafur (UFT) in Patients with Advanced Biliary Tract Carcinoma (2005)
Ikeda, Masafumi, Okusaka, Takuji, Ueno, Hideki, Morizane, Chigusa, Furuse, Junji, Ishii, Hiroshi
Background: Uracil-tegafur (UFT) has been reported to have broad antitumor activity in a variety of malignancies. However, its activity in biliary tract carcinoma has not been fully evaluated. The...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...
Ikeda, Masafumi, Okada, Shuichi, Yamamoto, Seiichiro, Sato, Tosiya, Ueno, Hideki, Okusaka, Takuji, ...
Background: Transcatheter arterial embolization induces marked antitumor response in patients with hepatocellular carcinoma, but the survival benefit of transcatheter arterial embolization remains to...
Phase I Trial of Gemcitabine in Patients with Advanced Pancreatic Cancer (2001)
Okada, Shuichi, Ueno, Hideki, Okusaka, Takuji, Ikeda, Masafumi, Furuse, Junji, Maru, Yasushi
Background: Gemcitabine is the most promising new agent currently being tested in pancreatic cancer. The present study was conducted to confirm the tolerability of a weekly schedule of gemcitabine at...
Ikeda, Masafumi, Okada, Shuichi, Ueno, Hideki, Okusaka, Takuji, Kuriyama, Hitoshi
Spontaneous regression of hepatocellular carcinoma is an extraordinarily unusual phenomenon. We present here a case of a 75-year-old man in whom multiple lung metastases of hepatocellular carcinoma...
Ikeda, Masafumi, Okada, Shuichi, Ueno, Hideki, Okusaka, Takuji, Kuriyama, Hitoshi
Background: Radiofrequency ablation (RFA) is a novel thermal ablation technique to achieve coagulative necrosis of hepatocellular carcinoma. A study was conducted to compare the antitumor effect and...